Pharma
The pharma giant is collaborating with sports tech firm Supersapiens.
The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics' tech platform.
The paper discusses the potenital for collecting real-world data, recruiting patients and using APIs.
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015.
Under the banner of the Consumer Technology Association, the companies hope that clear standards will improve digital therapeutics adoption and implementation.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs.
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
The CARE consortium will accelerate R&D by bringing together expertise from research institutions and pharmaceutical companies.
Major pharmacies and services say they're unaffected by USPS troubles so far, but some online platforms that rely on the service are worried about their patients and long-term business.